Next Article in Journal
The Potential Protective Effect and Possible Mechanism of Peptides from Oyster (Crassostrea hongkongensis) Hydrolysate on Triptolide-Induced Testis Injury in Male Mice
Previous Article in Journal
Potential Biomedical Applications of Collagen Filaments derived from the Marine Demosponges Ircinia oros (Schmidt, 1864) and Sarcotragus foetidus (Schmidt, 1862)
Previous Article in Special Issue
Evaluation of Aqueous Biphasic Electrophoresis System Based on Halide-Free Ionic Liquids for Direct Recovery of Keratinase
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 19
Issue 10
10.3390/md19100564
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

ARTP Mutagenesis of Schizochytrium sp. PKU#Mn4 and Clethodim-Based Mutant Screening for Enhanced Docosahexaenoic Acid Accumulation

by
Lu Liu
1,
Mohan Bai
1,
Sai Zhang
1,2,
Jiantao Li
1,
Xianhua Liu
1,
Biswarup Sen
1,* and
Guangyi Wang
1,3,*
1
Center for Marine Environmental Ecology, School of Environmental Science and Engineering, Tianjin University, Tianjin 300072, China
2
Polar Research Institute of China, Shanghai 200136, China
3
Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300072, China
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2021, 19(10), 564; https://doi.org/10.3390/md19100564
Submission received: 15 September 2021 / Revised: 29 September 2021 / Accepted: 4 October 2021 / Published: 7 October 2021
(This article belongs to the Special Issue Marine Enzymes: Sources, Biochemistry and Bioprocesses for Marine Biotechnology – III)
Browse Figures
Versions Notes

Abstract

:
Schizochytrium species are one of the best oleaginous thraustochytrids for high-yield production of docosahexaenoic acid (DHA, 22:6). However, the DHA yields from most wild-type (WT) strains of Schizochytrium are unsatisfactory for large-scale production. In this study, we applied the atmospheric and room-temperature plasma (ARTP) tool to obtain the mutant library of a previously isolated strain of Schizochytrium (i.e., PKU#Mn4). Two rounds of ARTP mutagenesis coupled with the acetyl-CoA carboxylase (ACCase) inhibitor (clethodim)-based screening yielded the mutant A78 that not only displayed better growth, glucose uptake and ACCase activity, but also increased (54.1%) DHA content than that of the WT strain. Subsequent optimization of medium components and supplementation improved the DHA content by 75.5 and 37.2%, respectively, compared with that of mutant A78 cultivated in the unoptimized medium. Interestingly, the ACCase activity of mutant A78 in a medium supplemented with biotin, citric acid or sodium citrate was significantly greater than that in a medium without supplementation. This study provides an effective bioengineering approach for improving the DHA accumulation in oleaginous microbes.

1. Introduction

As one of the most important polyunsaturated fatty acids (PUFA), docosahexaenoic acid (DHA, 22:6) not only benefits the development of the fetus’s nerves and retina but also prevents several human diseases such as cardiovascular disease, hypertension and thrombi [1]. Given the multiple benefits to human health, DHA has been an important functional food component with high demand on the global market. However, due to the lack of a complete PUFA biosynthesis pathway, humans can only obtain DHA from dietary supplements. As the current major source of DHA, deep-sea fishes obtain PUFA from marine microorganisms, particularly marine microalgae and protists [2,3,4]. Unfortunately, the supply of fish oil is limited by food security, environmental and toxicity concerns and, therefore, further research is needed to develop efficient and sustainable alternative sources of DHA [5].
Thraustochytrids, a group of unicellular heterotrophic protists with ubiquitous presence in marine environments [6,7], are widely used in the production of DHA [8]. However, the low production yield of most thraustochytrid strains remains to be a key limiting factor for large-scale DHA production. To date, the efforts on improving the production yield of thraustochytrid strains have mostly focused on the optimization of media components, such as carbon and nitrogen sources [9,10,11,12,13] and salinity [11]. While several other efforts were focused on the manipulation of fermentation parameters, e.g., pH [14], aeration rates [15], feeding strategies [12,16] and multiple-stage cultivation strategies [17]. However, the scale of DHA production solely through the optimizations of such traditional fermentation strategies has not been quite remarkable and is largely limited by the non-availability of strains/mutants with high DHA accumulation capacity.
Strain improvements through mutagenesis, including physical and chemical methods, are one of the most commonly used approaches to obtain mutants with desirable biological and biotechnological traits [18,19,20,21,22]. For example, the atmospheric and room-temperature plasma (ARTP) mutagenesis technology can generate microbial mutation by using helium radio frequency glow discharge plasma jets [23]. Compared with the other conventional mutation methods, ARTP has several advantages, including high efficiency, consistency, nontoxicity, environment-friendly and low cost [24]. As of now, ARTP mutagenesis technology has been used for successful microbial breeding of bacteria [25], fungi [26] and microalgae [19,27]. Furthermore, ARTP mutagenesis has shown notable improvement in the production yields of several microbial products, e.g., 1,3-propanediol [28], hydrogen production [29], high acid protease [30] and lycopene [26]. Despite so, the research on the application of ARTP technology to generate thraustochytrid mutants towards achieving a high DHA yield is still in its infancy [31].
After mutagenesis, the subsequent efficient screening method is the pivotal step to obtain mutant strains with desirable features [32]. Most conventional screening methods, such as phenotypic and morphological screening, can be tedious and time-consuming [33]. Therefore, more effective screening methods are critical for developing strains of oleaginous microbes with the ability to produce high amounts of fatty acids [32]. Acetyl-CoA carboxylase (ACCase), which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, is the first committing step in the fatty acids biosynthetic pathway [34]. Upregulation of ACCase activities has been demonstrated to significantly improve the lipid production in several oleaginous microorganisms [35,36,37,38]. Furthermore, an ACCase inhibitor (sethoxydim)-based screening strategy has been successfully used to screen mutants of Crypthecodinium cohnii with high DHA yields [39].
Clethodim, which has been reported as a commonly used herbicide to control grass weeds growth by inhibiting ACCase [40], was found to significantly inhibit the growth of Schizochytrium sp. PKU#Mn4. In this study, we applied the ARTP mutagenesis technology in combination with a screening strategy that is based on clethodim—an ACCase inhibitor—to screen for high DHA yielding mutants of Schizochytrium sp. PKU#Mn4. Through media optimization, including supplementation of chemical modulators/activators of fatty acids biosynthesis, DHA production of the best mutant was further improved. This study provides the first report of a bioengineering approach, integrating ARTP mutagenesis and clethodim-based screening strategy, which yielded a thraustochytrid mutant with a better capacity for DHA accumulation than its parental strain.

2. Results

2.1. Optimal ARTP Exposure Time and Clethodim Concentration

The lethality (%) of ARTP treatment to the cells of strain PKU#Mn4 increased with the ARTP exposure time in a sigmoid pattern (Figure 1a). The lethality increased sharply between 30 s and 40 s and thereafter leveled off. The treatment duration of 40 s with the lethality of 96.4% was, therefore, chosen as the optimal duration time of ARTP treatment for strain PKU#Mn4.
Clethodim addition into the culture medium resulted in the growth inhibition of strain PKU#Mn4 (Figure 1b). The number of surviving colonies decreased significantly as clethodim concentration increased. The lethality (%) of clethodim exhibited a linear increase between 0 µg/mL and 60 µg/mL and thereafter leveled off. The clethodim concentration of 80 µg/mL, which yielded 94% lethality, was used to screen the mutants with high ACCase activity. In the second round of screening, clethodim at a concentration of 95 µg/mL was used to screen the resulting mutants.

2.2. Mutant Screening

The first round of mutagenesis and subsequent clethodim-based screening yielded 13 mutants with better DHA content. Among these, four mutants, namely B13, B14, B15 and B22, were further selected because of their relatively higher DHA content compared with that of the WT strain (Figure S1). From the second round of ARTP mutagenesis of these four mutants followed by clethodim-based screening, 17 mutant strains with improved DHA content were obtained. The biomass and DHA contents of these 17 mutant strains were significantly higher than that of the WT strain (Table 1). In addition, the percentage of DHA in TFA was improved in all these mutants compared with that of the WT strain. Particularly, the mutants A99, A29, A74, A89, A78 and A22 were able to accumulate DHA by more than 1.5-fold and palmitic acid by more than 1.4-fold (Table S1). However, the genetic stability test indicated that only mutant A78 was stable, which showed a 54.1% increase in DHA content and was, therefore, used in further optimization experiments.

2.3. Dynamics of Growth, Glucose Consumption and ACCase Activity in Mutant A78

The mutant A78 showed significantly higher growth and glucose consumption compared with the WT strain between 24 h and 60 h of cultivation in the M4 medium (Figure 2). The ACCase activity of both mutant A78 and WT strain peaked at 24 h of cultivation (Figure 2); however, the peak ACCase activity of mutant A78 was 1.6-fold that of WT strain. Moreover, the ACCase activity of mutant A78 was specifically higher than that of the WT strain between 12 and 24 h of cultivation. In addition, after 60 h of cultivation, the ACCase activity of mutant A78 remained slightly lower than or close to that of the WT strain.

2.4. Effects of Media Components on DHA Accumulation in Mutant A78

The influence of various carbon and nitrogen sources on the DHA accumulation in mutant A78 was evaluated in this study. Glucose, glycerol and mannose were found as potential carbon sources (Figure 3a), while yeast extract, peptone, peptone plus yeast extract and corn steep liquor as potential nitrogen sources (Figure 3b), for achieving a significant amount of biomass and TFA. Glucose (40 g/L) and yeast extract (7.5 g/L) yielded the best DHA content, i.e., 1.21 and 1.19 g/L, respectively (Figure 4a). Further evaluation of various sea salt concentrations revealed that biomass and TFA contents of mutant A78 are not much affected by the change in the sea salt concentration, except for a slight increase in DHA production (Figure 4a).
Furthermore, the addition of biotin, citric acid, or sodium citrate to the M4 medium showed no significant effect on the biomass and TFA contents of mutant A78 (Figure 4b). However, biotin and sodium citrate supplementation could increase the PUFA content to 1.44 and 1.45 g/L, respectively. The DHA contents achieved with biotin and sodium citrate supplementation were 1.07 and 1.13 g/L, an increase of 13.8 and 20.2%, respectively. Contrastingly, the addition of citric acid to the M4 medium had an insignificant effect on the DCW, TFA and DHA contents, except that it could increase the PUFA content by 9.0%. Further analysis of the ACCase activity of the mutant A78 revealed that biotin, citric acid and sodium citrate supplementation to M4 medium could increase the ACCase activity by 40, 58 and 38%, respectively (Figure 5).

2.5. Improved DHA Accumulation in Mutant A78 through Media Optimization

To improve the DHA accumulation in mutant A78, two different sets of orthogonal experiments were conducted. The first set of experiments included three levels of glucose, yeast extract and sea salt (Table 2), while the second set of experiments included three levels of biotin (A), citric acid (B) and sodium citrate (C) (Table 3). The culture medium designed with the first set of orthogonal experiments, containing 40 g/L glucose (A2), 7.5 g/L yeast extract (B2) and 50% seawater (C1), yielded a DHA content of 1.65 g/L, which was 1.76-fold that with M4 medium (Figure 6). The initial C/N ratio of this optimal medium was 15.0. In addition, the DCW, TFA and PUFA contents also increased by 41.3, 34.2 and 51.6%, respectively (Figure 6). The contradiction was explained by the inhibition of high glucose concentration on cell growth and fatty acid synthesis. On the other hand, the culture medium designed with the second set of orthogonal experiments, containing 0.3 g/L biotin (A1), 0.5 g/L sodium citrate (B1) and 0.5 g/L citric acid (C1), could only increase the PUFA and DHA contents by 27.9 and 37.2%, respectively.

3. Discussion

ARTP has been widely used as a powerful and environmentally-friendly mutagenesis tool for generating mutant libraries and improving the yield of the target product from a variety of microorganisms [31,41]. Like other conventional mutagenesis methods, the treatment duration can be critical for achieving the desirable mutation efficiency [42]. In this study, Schizochytrium sp. PKU#Mn4 was found to be sensitive to the ARTP exposure time (Figure 1a). The optimal exposure time (40 s) of ARTP treatment to strain PKU#Mn4 was comparable with that of the microalgae such as Crypthecodinium cohni [39], Spirulina platensis [19], Chlorella pyrenoidosa [43] and Spirulina platensis [44]. However, compared with fungi, e.g., Monascus purpureus LQ-6 [45] and Aspergillus niger [46], the strain PKU#Mn4 was much more sensitive to the exposure time. These reported differences in the treatment duration could be attributed to the differential biochemical features of the microalgal and fungal cell walls that act as a natural barrier against environmental pressures [47]. Schizochytrium species have a thin non-cellulosic cell wall with galactose as the principal monosaccharide [48,49] and the thin cell wall is much easily penetrated by the high energy that leads to severe damage to DNA and proteins [50,51]. Our findings form the basis for future efforts to investigate how ARTP treatment affects the biochemical features of thraustochytrid species.
The modulatory or inhibitory role of chemicals in fatty acids biosynthesis has been commonly exploited to generate mutants with a great capacity for DHA or PUFA accumulation. For example, 2, 2’-Dipyridyl, an inducer of reactive oxygen species, was successfully used to screen mutants of Schizochytrium with a high antioxidant capacity [52]. Two inhibitors (isoniazid and triclosan) of enoyl-ACP reductase of Type II FAS pathway combined with cold stress were applied to screen mutants of Aurantiochytrium sp. Some other studies developed screening strategies based on malonic acid and iodoacetate acid to enrich the acetyl–CoA and NADPH pool, which resulted in mutants of Schizochytrium with 1.8-fold [53] and 2.0-fold change in DHA accumulation [54]. Unfortunately, the growths of most of these previously reported mutants of Schizochytrium were negatively affected [53,54,55]. In another study, a novel strategy of ARTP mutagenesis coupled with stepped malonic acid and zeocin resistance screening was applied to generate mutants of Schizochytrium sp. S31, which yielded a mutant mz-17 with a 1.8-fold in DHA [31]. Interestingly, in our study, the mutant A78, resulting from the clethodim-based screening, indicated that it cannot only accumulate 75.5% higher DHA but also had 41.3% higher biomass than that of the WT strain when cultivated in optimal medium (Figure 6). The improvement of both the biomass and lipid contents demonstrated the effectiveness of the clethodim-based screening compared with the aforementioned screening strategies. Our study provides a new screening strategy based on clethodim for efficient breeding of Schizochytrium with high DHA content but without much affecting the cell growth.
Earlier studies have demonstrated that ACCase activity plays a key role in fatty acids biosynthesis in lipogenic tissues of mammals [56] and cells of Escherichia coli [57]. ACCase activation via enzyme activators (e.g., citric acid and Mg2+) could enhance the microalgal lipid accumulation by almost 2-fold in Chlorella vulgaris [58]. The expression level of the ACCase gene in Chlorella sorokiniana was found to be upregulated by 2.1-fold from the exponential to stationary phase, indicating that ACCase gene expression is important in lipid biosynthesis [59]. Furthermore, transcriptomics analysis also indicated a closed association between upregulated ACCase and lipid accumulation in Chlorella ellipsoidea [60]. In this study, the two rounds of ARTP mutagenesis coupled with the ACCase inhibitor (clethodim)-based screening yielded the mutant A78. The increased DHA content of mutant A78 at 96 h of fermentation was consistent with its increased ACCase activity in the early exponential phase (24 h) of fermentation (Figure 4b and Figure 5), which suggested that DHA accumulation and ACCase activity are closely associated. Furthermore, when biotin was supplemented to the M4 medium, the ACCase activity of the mutant A78 was relatively increased, which indicated that biotin has a direct role in ACCase activity. As a cofactor for several essential carboxylase enzymes, biotin has been reported to be an important factor for the enzymatic activity of ACCase [61]. In addition, the enzyme ACCase is a biotin-dependent carboxylase and, therefore, biotin is important for its activity. In addition, biotin has been used as a media supplement to enhance fatty acids production in several thraustochytrid strains [62,63] and as a component of vitamin mixture [64]. Our findings suggest that ACCase would be an interesting target for engineering efficient strains of Schizochytrium in future studies.
Citric acid, a major intermediate of the tricarboxylic acid cycle, is known to play an important role in the biosynthesis of fatty acids [65]. However, in this study, citric acid did not much improve the DHA production (Figure 4b), probably because of the resulting acidic environment that has been reported unsuitable for cell growth and lipid accumulation of Schizochytrium sp. [66]. On the other hand, the aqueous solution of the sodium citrate is weakly alkaline and it can dissociate to form citrate ions, which can be catalyzed by the ATP:citrate lyase into acetyl-CoA—a key precursor used for lipid biosynthesis in oleaginous microorganisms [65]. Therefore, the addition of sodium citrate may not only buffer the culture environment but can also provide precursors for DHA synthesis. Overall, the results of citric acid and sodium citrate additions to the culture medium revealed that sodium citrate is a better supplement for improving the DHA accumulation of mutant A78.

4. Materials and Methods

4.1. Strain and Seed Culture

A previously isolated thraustochytrid strain, Schizochytrium sp. PKU#Mn4 [67], was used as the wild-type (WT) strain for ARTP mutagenesis. The strain was subcultured every two weeks on M4 solid medium containing (per liter) 20 g glucose, 1.5 g peptone, 1 g yeast extract, 33 g sea salt, 20 g agar and 1000 mL water. Seed culture was prepared in 100 mL glass flasks containing 40 mL M4 medium at 28 °C, 150 rpm for 24 h, which was used as the inoculum (5%, v/v) in all experiments. The C/N ratio of the initial M4 medium was 24.7, which was calculated based on the method described elsewhere [68].

4.2. Quantification of DCW, TFA and ACCase Activity

Cells were harvested by centrifuging at 4000 rpm for 10 min and then washed twice with sterile water. After lyophilization, the DCW of the harvested cells was estimated by the gravimetric method [67]. Lipid extraction, transesterification and quantification of fatty acids were performed following the procedures described in our previous studies [7,11]. The ACCase activity was detected by Acetyl-CoA Carboxylase ELISA Kit (Meimian Co., Jiangsu, China). All analyses were carried out in triplicate.

4.3. Sensitivity Assay of Schizochytrium sp. PKU#Mn4 to Clethodim

An 80 μL of 1000× 24 h grown PKU#Mn4 culture was spread on M4 medium plates, each containing a different concentration (0 to 100 μg/mL) of clethodim and cultivated at 28 °C for 72 h. For each concentration of clethodim, three replicate plates were set up. The individual colonies on the plates were counted manually and the lethality (%) was determined using Equation (1).
L e t h a l i t y   ( % ) =   Control   colonies   − S u r v i v a l   c o l o n i e s C o n t r o l   c o l o n i e s × 100

4.4. ARTP Mutagenesis and Clethodim-Based Screening

A 10 μL seed culture suspension was evenly spread on the sterile metal plate and then treated with pure helium plasma under 120 W radiofrequency power input and 10 SLM helium flow rate using an ARTP Breeding Mutagenesis Machine (ARTP-M model, Yuanqing Tianmu Biotechnology Co., Ltd., Wuxi, China). The metal plate was immediately placed into a sterilized tube containing 1 mL of M4 medium after mutagenesis. An appropriate dilution of the resulting cell suspension was spread on M4 medium plates and cultivated at 28 °C for 72 h. The colonies were counted manually and the lethality of the ARTP treatment was calculated using Equation (1).
The mutants appearing on the plates were picked and inoculated into 100 mL flasks, each containing 40 mL of M4 medium and cultivated for 72 h. An 80 μL of that culture (1000×) was spread onto fresh M4 medium plates supplemented with clethodim (80 μg per mL of medium). The resulting plates were incubated at 28 °C for 72 h and the mutants appearing on the plates were picked and inoculated into 100 mL flasks, each containing 40 mL of M4 medium. The flasks were then incubated at 28 °C for 24 h and the resulting culture broth in each flask was used for the quantification of fatty acids. The colonies were first selected based on their colony size and growth on plates and then based on their DHA content in flask culture. The mutants with improved DHA content were selected as the starting strain for the second round of ARTP mutagenesis (40 s) and clethodim-based screening. The second round of mutagenesis and screening was conducted in the same manner as the first one, but with a slightly higher concentration (95 μg/mL) of clethodim for screening.

4.5. Genetic Stability of the Mutants

The mutant strains were first cultured on plates with M4 solid medium at 28 °C for 96 h. Then, several colonies were streaked onto new plates with M4 solid medium and subcultured for 96 h. Each selected mutant was subcultured six times, i.e., six generations. The mutant colonies from each subculturing were simultaneously inoculated in liquid M4 medium and incubated at 28 °C for 24 h. The resulting culture broth was used as the inoculum (5%, v/v) for the quantification of DCW and fatty acids. The genetic stability of the mutants was evaluated by monitoring the DCW and DHA yield across six generations.

4.6. Medium Optimization

The effects of medium components (carbon, nitrogen and sea salt) and supplements (biotin, citric acid and sodium citrate) on the biomass and DHA content of the mutant A78 were evaluated using a one-factor-at-a-time (OFAT) experimental design. Various carbon sources (glucose, glycerol, mannose, sucrose, lactose and rhamnolipid) at 20 g/L while nitrogen sources (peptone, yeast extract, peptone plus yeast extract, ammonium chloride, sodium glutamate, corn steep liquor, ammonium sulfate and urea) at 2.5 g/L were screened. To further obtain the optimal levels of the medium components and supplements, 9-run orthogonal experimental designs (Table 1 and Table 2) were formulated based on the significant factor levels determined from OFAT experiments. Triplicate samples were analyzed for each experiment. The orthogonal experiment was designed and statistically analyzed using ANOVA in SPSS Statistic 19 software. The C/N ratio of the initial optimal medium was calculated based on the method described elsewhere [68].

4.7. Statistical Analyses

The mean, SD and the test of significance (ANOVA) for each parameter were computed in SPSS Statistic 19.5. (IBM, New York, NY, USA)

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/md19100564/s1, Figure S1: Biomass and DHA contents of the wild-type strain PKU#Mn4 and its mutants resulting from the first round of ARTP mutagenesis and clethodim (80 μg/mL)-based screening. WT strain and mutants were cultured in an M4 medium and the culture samples were collected at 96 h for biomass and DHA quantification; Table S1: Palmitic acid content of the wild-type strain PKU#Mn4 and its mutants obtained from the second round of ARTP mutagenesis and clethodim-based screening.

Author Contributions

Conceptualization, L.L., S.Z., J.L. and G.W.; methodology, J.L., L.L. and S.Z.; formal analysis, L.L., J.L., S.Z. and B.S.; investigation, J.L., L.L., S.Z. and M.B.; resources, M.B. and X.L.; data curation, L.L., J.L. and B.S.; visualization, L.L. and B.S.; project administration, M.B. and X.L.; writing—original draft preparation, L.L., G.W. and B.S.; writing—review and editing, B.S. and G.W.; supervision, G.W.; funding acquisition, G.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Natural Science Foundation NSFC (32170063) granted to G.W.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Horrocks, L.A.; Yeo, Y.K. Health Benefits of Docosahexaenoic Acid (DHA). Pharmacol. Res. 1999, 40, 211–225. [Google Scholar] [CrossRef] [Green Version]
  2. Martins, D.A.; Custódio, L.; Barreira, L.; Pereira, H.; Ben-Hamadou, R.; Varela, J.; Abu-Salah, K.M. Alternative sources of n-3 long-chain polyunsaturated fatty acids in marine microalgae. Mar. Drugs 2013, 11, 2259–2281. [Google Scholar] [CrossRef] [Green Version]
  3. Ward, O.P.; Singh, A. Omega-3/6 fatty acids: Alternative sources of production. Process Biochem. 2005, 40, 3627–3652. [Google Scholar] [CrossRef]
  4. Sargent, J.R. Fish oils and human diet. Br. J. Nutr. 1997, 78 (Suppl. 1), S5–S13. [Google Scholar] [CrossRef]
  5. Lenihan-Geels, G.; Bishop, K.S.; Ferguson, L.R. Alternative sources of omega-3 fats: Can we find a sustainable substitute for fish? Nutrients 2013, 5, 1301–1315. [Google Scholar] [CrossRef]
  6. Singh, P.; Liu, Y.; Li, L.; Wang, G. Ecological dynamics and biotechnological implications of thraustochytrids from marine habitats. Appl. Microbiol. Biotechnol. 2014, 98, 5789–5805. [Google Scholar] [CrossRef] [PubMed]
  7. Wang, Q.; Ye, H.; Xie, Y.; He, Y.; Sen, B.; Wang, G. Culturable Diversity and Lipid Production Profile of Labyrinthulomycete Protists Isolated from Coastal Mangrove Habitats of China. Mar. Drugs 2019, 17, 268. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Marchan, L.F.; Chang, K.J.L.; Nichols, P.D.; Mitchell, W.J.; Polglase, J.L.; Gutierrez, T. Taxonomy, ecology and biotechnological applications of thraustochytrids: A review. Biotechnol. Adv. 2018, 36, 26–46. [Google Scholar] [CrossRef] [PubMed]
  9. Jiang, X.; Li, Y.; Ji, H.; Zhang, X.; Hu, X.; Zhu, G.; Lu, H.; Zhong, M. Optimization of cultivation conditions for DHA production by Schizochytrium sp. 20888. Microbiol. China 2016, 43, 1199–1209. [Google Scholar]
  10. Jiang, X.; Zhang, J.; Zhao, J.; Gao, Z.Q.; Zhang, C.Z.; Chen, M. Regulation of lipid accumulation in Schizochytrium sp ATCC 20888 in response to different nitrogen sources. Eur. J. Lipid Sci. Tech. 2017, 119, 8. [Google Scholar] [CrossRef]
  11. Wang, Q.; Ye, H.; Sen, B.; Xie, Y.; He, Y.; Park, S.; Wang, G. Improved production of docosahexaenoic acid in batch fermentation by newly-isolated strains of Schizochytrium sp. and Thraustochytriidae sp. through bioprocess optimization. Synth. Sys. Biotechnol. 2018, 3, 121–129. [Google Scholar] [CrossRef]
  12. Ye, H.; He, Y.; Xie, Y.; Sen, B.; Wang, G. Fed-batch fermentation of mixed carbon source significantly enhances the production of docosahexaenoic acid in Thraustochytriidae sp. PKU#Mn16 by differentially regulating fatty acids biosynthetic pathways. Bioresour. Technol. 2020, 297, 122402. [Google Scholar]
  13. Chen, X.; He, Y.; Ye, H.; Xie, Y.; Sen, B.; Jiao, N.; Wang, G. Different carbon and nitrogen sources regulated docosahexaenoic acid (DHA) production of Thraustochytriidae sp. PKU#SW8 through a fully functional polyunsaturated fatty acid (PUFA) synthase gene (pfaB). Bioresour. Technol. 2020, 318, 124273. [Google Scholar]
  14. Yin, F.W.; Zhang, Y.T.; Jiang, J.Y.; Guo, D.S.; Gao, S.; Gao, Z. Efficient docosahexaenoic acid production by Schizochytrium sp. via a two-phase pH control strategy using ammonia and citric acid as pH regulators. Process Biochem. 2019, 77, 1–7. [Google Scholar] [CrossRef]
  15. Guo, D.S.; Ji, X.J.; Ren, L.J.; Li, G.L.; Yin, F.W.; Huang, H. Development of a real-time bioprocess monitoring method for docosahexaenoic acid production by Schizochytrium sp. Bioresour. Technol. 2016, 216, 422–427. [Google Scholar] [CrossRef] [Green Version]
  16. Guo, D.S.; Tong, L.L.; Ji, X.J.; Ren, L.J.; Ding, Q.Q. Development of a strategy to improve the stability of culture environment for docosahexaenoic acid fermentation by Schizochytrium sp. Appl. Biochem. Biotechnol. 2020, 192, 881–894. [Google Scholar] [CrossRef] [PubMed]
  17. Yin, F.W.; Zhu, S.Y.; Guo, D.S.; Ren, L.J.; Ji, X.J.; Huang, H.; Gao, Z. Development of a strategy for the production of docosahexaenoic acid by Schizochytrium sp from cane molasses and algae-residue. Bioresour. Technol. 2019, 271, 118–124. [Google Scholar] [CrossRef]
  18. Liang, Y.-M.; Liu, Y.; Li, J.-J.; Maurycy, D.; Cheng, J.J. Screening of high docosahexanoic acid yield mutants of Aurantiochytrium sp. PKU#SW7. Microbiol. China 2016, 43, 457–464. [Google Scholar]
  19. Fang, M.; Jin, L.; Zhang, C.; Tan, Y.; Jiang, P.; Ge, N.; Heping, L.; Xing, X. Rapid mutation of Spirulina platensis by a new mutagenesis system of atmospheric and room temperature plasmas (ARTP) and generation of a mutant library with diverse phenotypes. PLoS ONE 2013, 8, e77046. [Google Scholar] [CrossRef] [PubMed]
  20. Hlavova, M.; Turoczy, Z.; Bisova, K. Improving microalgae for biotechnology–from genetics to synthetic biology. Biotechnol. Adv. 2015, 33, 1194–1203. [Google Scholar] [CrossRef] [PubMed]
  21. Tanadul, O.U.; Noochanong, W.; Jirakranwong, P.; Chanprame, S. EMS-induced mutation followed by quizalofop-screening increased lipid productivity in Chlorella sp. Bioprocess Biosyst. Eng. 2018, 41, 613–619. [Google Scholar] [CrossRef] [PubMed]
  22. Zou, R.S.; Li, S.; Zhang, L.L.; Zhang, C.; Han, Y.J.; Gao, G.; Sun, X.; Gong, X. Mutagenesis of Rhodobacter sphaeroides using atmospheric and room temperature plasma treatment for efficient production of coenzyme Q10. J. Biosci. Bioeng. 2019, 127, 698–702. [Google Scholar] [CrossRef]
  23. Ottenheim, C.; Nawrath, M.; Wu, J.C. Microbial mutagenesis by atmospheric and room-temperature plasma (ARTP): The latest development. Bioresour. Bioprocess. 2018, 5, 12. [Google Scholar] [CrossRef] [Green Version]
  24. Wang, X.; Lu, M.; Wang, S.; Fang, Y.; Wang, D.; Ren, W.; Zhao, G. The atmospheric and room-temperature plasma (ARTP) method on the dextranase activity and structure. Int. J. Biol. Macromol. 2014, 70, 284–291. [Google Scholar] [CrossRef]
  25. Ma, Y.; Yang, H.; Chen, X.; Sun, B.; Du, G.; Zhou, Z.; Song, J.; Fan, Y.; Shen, W. Significantly improving the yield of recombinant proteins in Bacillus subtilis by a novel powerful mutagenesis tool (ARTP): Alkaline alpha-amylase as a case study. Protein Expr. Purif. 2015, 114, 82–88. [Google Scholar] [CrossRef]
  26. Wang, Q.; Feng, L.-R.; Wei, L.; Li, H.-G.; Wang, L.; Zhou, Y.; Yu, X.-B. Mutation breeding of lycopene-producing strain Blakeslea Trispora by a novel atmospheric and room temperature plasma (ARTP). Appl. Biochem. Biotechnol. 2014, 174, 452–460. [Google Scholar]
  27. Choi, J.-I.; Yoon, M.; Joe, M.; Park, H.; Lee, S.G.; Han, S.J.; Lee, P.C. Development of microalga Scenedesmus dimorphus mutant with higher lipid content by radiation breeding. Bioprocess Biosyst. Eng. 2014, 37, 2437–2444. [Google Scholar] [CrossRef]
  28. Yang, M.; An, Y.; Zabed, H.M.; Guo, Q.; Yun, J.; Zhang, G.; Awad, F.N.; Sun, W.; Qi, X. Random mutagenesis of Clostridium butyricum strain and optimization of biosynthesis process for enhanced production of 1,3-propanediol. Bioresour. Technol. 2019, 284, 188–196. [Google Scholar] [CrossRef]
  29. Ban, S.; Lin, W.; Luo, Z.; Luo, J. Improving hydrogen production of Chlamydomonas reinhardtii by reducing chlorophyll content via atmospheric and room temperature plasma. Bioresour. Technol. 2019, 275, 425–429. [Google Scholar] [CrossRef]
  30. Shu, L.; Si, X.G.; Yang, X.D.; Ma, W.Y.; Sun, J.L.; Zhang, J.; Xue, X.L.; Wang, D.P.; Gao, Q. Enhancement of acid protease activity of Aspergillus oryzae using atmospheric and room temperature plasma. Front. Microbiol. 2020, 11, 01418. [Google Scholar] [CrossRef] [PubMed]
  31. Zhao, B.; Li, Y.; Li, C.; Yang, H.; Wang, W. Enhancement of Schizochytrium DHA synthesis by plasma mutagenesis aided with malonic acid and zeocin screening. Appl. Microbiol. Biotechnol. 2018, 102, 2351–2361. [Google Scholar] [CrossRef]
  32. Li, X.; Liu, R.; Li, J.; Chang, M.; Liu, Y.; Jin, Q.; Wang, X. Enhanced arachidonic acid production from Mortierella alpina combining atmospheric and room temperature plasma (ARTP) and diethyl sulfate treatments. Bioresour. Technol. 2015, 177, 134–140. [Google Scholar] [CrossRef]
  33. Gao, M.; Song, X.; Feng, Y.; Li, W.; Cui, Q. Isolation and characterization of Aurantiochytrium species: High docosahexaenoic acid (DHA) production by the newly isolated microalga, Aurantiochytrium sp SD116. J. Oleo Sci. 2013, 62, 143–151. [Google Scholar] [CrossRef] [Green Version]
  34. Diao, J.; Song, X.; Cui, J.; Liu, L.; Shi, M.; Wang, F.; Zhang, W. Rewiring metabolic network by chemical modulator based laboratory evolution doubles lipid production in Crypthecodinium cohnii. Metab. Eng. 2019, 51, 88–98. [Google Scholar] [CrossRef]
  35. Ma, C.; Ren, H.; Xing, D.; Xie, G.; Ren, N.; Liu, B. Mechanistic understanding towards the effective lipid production of a microalgal mutant strain Scenedesmus sp. Z-4 by the whole genome bioinformation. J. Hazard. Mater. 2019, 375, 115–120. [Google Scholar] [CrossRef] [PubMed]
  36. Huerlimann, R.; Steinig, E.J.; Loxton, H.; Zenger, K.R.; Jerry, D.R.; Heimann, K. The effect of nitrogen limitation on acetyl-CoA carboxylase expression and fatty acid content in Chromera velia and Isochrysis aff. galbana (TISO). Gene 2014, 543, 204–211. [Google Scholar] [CrossRef] [PubMed]
  37. Chaturvedi, R.; Uppalapati, S.R.; Alamsjah, M.A.; Fujita, Y. Isolation of quizalofop-resistant mutants of Nannochloropsis oculata (Eustigmatophyceae) with high eicosapentaenoic acid following N-methyl-N-nitrosourea-induced random mutagenesis. J. Appl. Phycol. 2004, 16, 135–144. [Google Scholar] [CrossRef]
  38. Davis, M.S.; Solbiati, J.; Cronan, J.E. Overproduction of acetyl-CoA carboxylase activity increases the rate of fatty acid biosynthesis in Escherichia coli. J. Biol. Chem. 2000, 275, 28593–28598. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Liu, J.; Pei, G.; Diao, J.; Chen, Z.; Liu, L.; Chen, L.; Zhang, W. Screening and transcriptomic analysis of Crypthecodinium cohnii mutants with high growth and lipid content using the acetyl-CoA carboxylase inhibitor sethoxydim. Appl. Microbiol. Biotechnol. 2017, 101, 6179–6191. [Google Scholar] [CrossRef] [PubMed]
  40. Yu, Q.; Collavo, A.; Zheng, M.Q.; Owen, M.; Sattin, M.; Powles, S.B. Diversity of acetyl-coenzyme a carboxylase mutations in resistant Lolium populations: Evaluation using clethodim. Plant Physiol. 2007, 145, 547–558. [Google Scholar] [CrossRef] [Green Version]
  41. Zhang, X.; Zhang, X.F.; Li, H.P.; Wang, L.Y.; Zhang, C.; Xing, X.H.; Bao, C.Y. Atmospheric and room temperature plasma (ARTP) as a new powerful mutagenesis tool. Appl. Microbiol. Biotechnol. 2014, 98, 5387–5396. [Google Scholar] [CrossRef]
  42. Laroussi, M. Low temperature plasma-based sterilization: Overview and state-of-the-art. Plasma Process. Polym. 2005, 2, 391–400. [Google Scholar] [CrossRef]
  43. Cao, S.; Zhou, X.; Jin, W.; Wang, F.; Tu, R.; Han, S.; Chen, H.; Chen, C.; Xie, G.-J.; Ma, F. Improving of lipid productivity of the oleaginous microalgae Chlorella pyrenoidosa via atmospheric and room temperature plasma (ARTP). Bioresour. Technol. 2017, 244, 1400–1406. [Google Scholar] [CrossRef]
  44. An, J.; Gao, F.; Ma, Q.; Xiang, Y.; Ren, D.; Lu, J. Screening for enhanced astaxanthin accumulation among Spirulina platensis mutants generated by atmospheric and room temperature plasmas. Algal Res. 2017, 25, 464–472. [Google Scholar] [CrossRef]
  45. Liu, J.; Guo, T.; Luo, Y.; Chai, X.; Wu, J.; Zhao, W.; Jiao, P.; Luo, F.; Lin, Q. Enhancement of Monascus pigment productivity via a simultaneous fermentation process and separation system using immobilized-cell fermentation. Bioresour. Technol. 2019, 272, 552–560. [Google Scholar] [CrossRef]
  46. Wang, B.; Tan, F.; Yu, F.; Li, H.; Zhang, M. Efficient biorefinery of whole cassava for citrate production using Aspergillus niger mutated by atmospheric and room temperature plasma and enhanced co-saccharification strategy. J. Sci. Food Agric. 2021, 101, 4613–4620. [Google Scholar] [CrossRef] [PubMed]
  47. Bernaerts, T.M.M.; Gheysen, L.; Kyomugasho, C.; Jamsazzadeh Kermani, Z.; Vandionant, S.; Foubert, I.; Hendrickx, M.E.; Van Loey, A.M. Comparison of microalgal biomasses as functional food ingredients: Focus on the composition of cell wall related polysaccharides. Algal Res. 2018, 32, 150–161. [Google Scholar] [CrossRef]
  48. Darley, W.M.; Porter, D.; Fuller, M.S. Cell wall composition and synthesis via Golgi-directed scale formation in the marine eucaryote, Schizochytrium aggregatum, with a note on Thraustochytrium sp. Arch. Mikrobiol. 1973, 90, 89–106. [Google Scholar] [CrossRef] [PubMed]
  49. Bahnweg, G.; Jckle, I. A new approach to taxonomy of the Thraustochytriales and Labyrinthulales. In The Biology of Marine Fungi; Moss, S.T., Ed.; Cambridge University Press: Cambridge, UK, 1986; pp. 131–140. [Google Scholar]
  50. Cooke, M.S.; Evans, M.D.; Dizdaroglu, M.; Lunec, J. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J. 2003, 17, 1195–1214. [Google Scholar] [CrossRef] [Green Version]
  51. Li, G.; Li, H.P.; Wang, L.Y.; Wang, S.; Zhao, H.X.; Sun, W.T.; Xing, X.H.; Bao, C.Y. Genetic effects of radio-frequency, atmospheric-pressure glow discharges with helium. Appl. Phys. Lett. 2008, 92, 3. [Google Scholar] [CrossRef] [Green Version]
  52. Yuan, J.; Zhao, B.; Sun, M.; Wang, W.; Yang, H. Rapid mutation breeding Schizochytrium strains producing high-yield docosahexenoic acid by atmospheric and room temperature plasmas (ARTP). Biotechnol. Bull. 2015, 31, 199–204. [Google Scholar]
  53. Gong, D.; Xiong, Y.; Sun, J.; Shi, Z. Mutation breeding Schizochytrium strains producing high-yield DHA via atmospheric and room temperature plasmas. China Oils Fats 2019, 44, 124–128. [Google Scholar]
  54. Lian, M.; Huang, H.; Ren, L.; Ji, X.; Zhu, J.; Jin, L. Increase of docosahexaenoic acid production by Schizochytrium sp through mutagenesis and enzyme assay. Appl. Biochem. Biotechnol. 2010, 162, 935–941. [Google Scholar] [CrossRef] [PubMed]
  55. Cheng, Y.R.; Sun, Z.J.; Cui, G.Z.; Song, X.; Cui, Q. A new strategy for strain improvement of Aurantiochytrium sp. based on heavy-ions mutagenesis and synergistic effects of cold stress and inhibitors of enoyl-ACP reductase. Enzym. Microb. Technol. 2016, 93–94, 182–190. [Google Scholar] [CrossRef] [PubMed]
  56. Liang, T.; Harwood, H.J. Acetyl-coenzyme A carboxylases: Versatile targets for drug discovery. J. Cell. Biochem. 2010, 99, 1476–1488. [Google Scholar]
  57. James, E.S.; Cronan, J.E. Expression of two Escherichia coli acetyl-CoA carboxylase subunits is autoregulated. J. Biol. Chem. 2004, 279, 2520–2527. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Hu, Q.; Zeng, R.; Zhang, S.-X.; Yang, Z.-H.; Huang, H. Production of microalgal lipids as biodiesel feedstock with fixation of CO2 by Chlorella vulgaris. Food Technol. Biotech. 2014, 52, 285–291. [Google Scholar]
  59. Wan, M.; Liu, P.; Xia, J.; Rosenberg, J.N.; Oyler, G.A.; Betenbaugh, M.J.; Nie, Z.; Qiu, G. The effect of mixotrophy on microalgal growth, lipid content, and expression levels of three pathway genes in Chlorella sorokiniana. Appl. Microbiol. Biotechnol. 2011, 91, 835–844. [Google Scholar] [CrossRef]
  60. Liu, X.; Zhang, D.; Zhang, J.; Chen, Y.; Liu, X.; Fan, C.; Wang, R.R.C.; Hou, Y.; Hu, Z. Overexpression of the transcription factor AtLEC1 significantly improved the lipid content of Chlorella ellipsoidea. Front. Bioeng. Biotechnol. 2021, 9, 626162. [Google Scholar] [CrossRef] [PubMed]
  61. Streit, W.R.; Entcheva, P. Biotin in microbes, the genes involved in its biosynthesis, its biochemical role and perspectives for biotechnological production. Appl. Microbiol. Biotechnol. 2003, 61, 21–31. [Google Scholar] [CrossRef]
  62. Quilodran, B.; Hinzpeter, I.; Hormazabal, E.; Quiroz, A.; Shene, C. Docosahexaenoic acid (C22:6n-3, DHA) and astaxanthin production by Thraustochytriidae sp AS4-A1 a native strain with high similitude to Ulkenia sp.: Evaluation of liquid residues from food industry as nutrient sources. Enzym. Microb. Technol. 2010, 47, 24–30. [Google Scholar] [CrossRef]
  63. Ugalde, V.; Armenta, R.E.; Kermanshahi-pour, A.; Sun, Z.; Berryman, K.T.; Brooks, M.S. Improvement of culture conditions for cell biomass and fatty acid production by marine thraustochytrid F24-2. J. Appl. Phycol. 2018, 30, 329–339. [Google Scholar] [CrossRef]
  64. Lee Chang, K.J.; Dumsday, G.; Nichols, P.D.; Dunstan, G.A.; Blackburn, S.I.; Koutoulis, A. High cell density cultivation of a novel Aurantiochytrium sp. strain TC 20 in a fed-batch system using glycerol to produce feedstock for biodiesel and omega-3 oils. Appl. Microbiol. Biotechnol. 2013, 97, 6907–6918. [Google Scholar] [CrossRef] [PubMed]
  65. Ratledge, C. Fatty acid biosynthesis in microorganisms being used for Single Cell Oil production. Biochimie 2004, 86, 807–815. [Google Scholar] [CrossRef] [PubMed]
  66. Wu, S.-T.; Yu, S.-T.; Lin, L.-P. Effect of culture conditions on docosahexaenoic acid production by Schizochytrium sp. S31. Process Biochem. 2005, 40, 3103–3108. [Google Scholar] [CrossRef]
  67. Liu, Y.; Singh, P.; Sun, Y.; Luan, S.; Wang, G. Culturable Diversity and Biochemical Features of Thraustochytrids from Coastal Waters of Southern China. Appl. Microbiol. Biotechnol. 2014, 98, 3241–3255. [Google Scholar] [CrossRef]
  68. Wang, Q.; Sen, B.; Liu, X.; He, Y.; Xie, Y.; Wang, G. Enhanced saturated fatty acids accumulation in cultures of newly-isolated strains of Schizochytrium sp. and Thraustochytriidae sp. for large-scale biodiesel production. Sci. Total Environ. 2018, 631–632, 994–1004. [Google Scholar] [CrossRef]
Marinedrugs 19 00564 g001 550
Figure 1. Effects of the exposure time of ARTP treatment (a) and clethodim levels (b) on the lethality of the WT strain.
Figure 1. Effects of the exposure time of ARTP treatment (a) and clethodim levels (b) on the lethality of the WT strain.
Marinedrugs 19 00564 g001
Marinedrugs 19 00564 g002 550
Figure 2. Comparison of the dynamics of biomass, glucose consumption and ACCase activity between the mutant A78 and the WT strain cultivated in the M4 medium. * p < 0.05.
Figure 2. Comparison of the dynamics of biomass, glucose consumption and ACCase activity between the mutant A78 and the WT strain cultivated in the M4 medium. * p < 0.05.
Marinedrugs 19 00564 g002
Marinedrugs 19 00564 g003 550
Figure 3. Biomass and fatty acids composition of mutant A78 cultivated on various (a) carbon sources (20 g/L) and (b) nitrogen sources (2.5 g/L). The bars represent the data for 96 h culture.
Figure 3. Biomass and fatty acids composition of mutant A78 cultivated on various (a) carbon sources (20 g/L) and (b) nitrogen sources (2.5 g/L). The bars represent the data for 96 h culture.
Marinedrugs 19 00564 g003
Marinedrugs 19 00564 g004 550
Figure 4. Biomass and fatty acid contents of mutant A78 cultivated in (a) M4 medium with optimal levels of glucose, yeast extract and sea salt and (b) M4 medium with optimal levels of biotin, citric acid and sodium citrate. Except for the studied factor in each OFAT experimental design, the other medium components and their concentrations were the same as that of the M4 medium. 60% seawater was equivalent to 19.8 g/L sea salt. The bars represent the data of 96 h culture. Significant (p < 0.01) differences are shown with different letters for each parameter.
Figure 4. Biomass and fatty acid contents of mutant A78 cultivated in (a) M4 medium with optimal levels of glucose, yeast extract and sea salt and (b) M4 medium with optimal levels of biotin, citric acid and sodium citrate. Except for the studied factor in each OFAT experimental design, the other medium components and their concentrations were the same as that of the M4 medium. 60% seawater was equivalent to 19.8 g/L sea salt. The bars represent the data of 96 h culture. Significant (p < 0.01) differences are shown with different letters for each parameter.
Marinedrugs 19 00564 g004
Marinedrugs 19 00564 g005 550
Figure 5. ACCase activity of mutant A78 cultivated in M4 medium supplemented with biotin, citric acid, or sodium citrate. The bars represent the data for 24 h culture. Significant (p < 0.05) differences are shown with different letters.
Figure 5. ACCase activity of mutant A78 cultivated in M4 medium supplemented with biotin, citric acid, or sodium citrate. The bars represent the data for 24 h culture. Significant (p < 0.05) differences are shown with different letters.
Marinedrugs 19 00564 g005
Marinedrugs 19 00564 g006 550
Figure 6. Comparison of biomass and fatty acids content of mutant A78 across different media conditions. The optimal medium/supplementation was determined from the orthogonal experiment. The optimal medium contained 40 g/L glucose, 7.5 g/L yeast extract and 50% of seawater, while the optimal supplements were 0.3 g/L biotin, 0.5 g/L citric acid and 0.5 g/L sodium citrate. The bars represent the data of 96 h culture. Significant (p < 0.01) differences are shown with different letters for each parameter.
Figure 6. Comparison of biomass and fatty acids content of mutant A78 across different media conditions. The optimal medium/supplementation was determined from the orthogonal experiment. The optimal medium contained 40 g/L glucose, 7.5 g/L yeast extract and 50% of seawater, while the optimal supplements were 0.3 g/L biotin, 0.5 g/L citric acid and 0.5 g/L sodium citrate. The bars represent the data of 96 h culture. Significant (p < 0.01) differences are shown with different letters for each parameter.
Marinedrugs 19 00564 g006
Table
Table 1. Biomass, total fatty acids and DHA content of the wild-type strain PKU#Mn4 and its mutants obtained from the second round of ARTP mutagenesis and clethodim-based screening.
Table 1. Biomass, total fatty acids and DHA content of the wild-type strain PKU#Mn4 and its mutants obtained from the second round of ARTP mutagenesis and clethodim-based screening.
Strain/MutantBiomass (g/L)TFA (g/L)DHA (g/L)DHA (g/g)DHA/TFA (%)
WT6.132.360.610.125.8
A106.42 (4.7%)2.47 (4.7%)0.87 ** (42.6%)0.14 (40%)35.2
A116.31 (2.9%)2.40 (1.7%)0.85 ** (39.3%)0.13 (30%)35.4
A176.47 (5.5%)2.44 (3.4%)0.87 ** (42.6%)0.13 (30%)35.7
A226.46 * (5.4%)2.66 (12.7%)0.92 ** (50.8%)0.14 (40%)34.6
A236.07 (−1.0%)2.55 (8.1%)0.87 ** (42.6%)0.14 (40%)34.1
A256.33 (3.3%)2.60 (10.2%)0.86 ** (41.0%)0.14 (40%)33.1
A296.71 * (9.5%)2.66 (12.7%)0.95 ** (55.7%)0.14 (40%)35.7
A366.49 * (5.9%)2.51 (6.4%)0.86 ** (41.0%)0.13 (30%)34.3
A496.59 * (7.5%)2.40 (1.7%)0.91 ** (49.2%)0.14 (40%)37.9
A546.28 * (2.4%)2.51 (6.4%)0.85 ** (39.3%)0.14 (40%)33.9
A746.75 ** (10.1%)2.49 (5.5%)0.95 ** (55.7%)0.14 (40%)38.2
A756.51 * (6.2%)2.74 (16.1%)0.87 ** (42.6%)0.13 (30%)31.8
A786.35 (3.6%) 2.81 * (19.1%)0.94 ** (54.1%)0.15 (50%)33.5
A816.85 ** (11.7%)2.48 (5.1%)0.83 ** (36.1%)0.12 (20%)33.5
A896.28 (2.4%)2.81 (19.1%)0.95 ** (55.7%)0.15 (50%)33.8
A926.27 (2.3%)2.72 (15.3%)0.87 ** (42.6%)0.14 (40%)32.0
A996.70 ** (9.3%)2.92 (23.7%)0.98 ** (60.7%)0.15 (50%)33.6
Note: The data are provided for the samples collected at 96 h of cultivation. * p < 0.05; ** p < 0.01. The data in parenthesis indicate the percent increase compared with the WT strain.
Table
Table 2. Factors and levels of the orthogonal experimental design for the optimal medium.
Table 2. Factors and levels of the orthogonal experimental design for the optimal medium.
ExperimentA
Glucose
(g/L)		B
Yeast Extract
(g/L)		C
Sea Salt
(%) *
1306.550
2407.560
3508.570
* 100% is equivalent to 33 g/L sea salt.
Table
Table 3. Factors and levels of the orthogonal experimental design for the optimal supplementation.
Table 3. Factors and levels of the orthogonal experimental design for the optimal supplementation.
ExperimentA
Biotin
(g/L)		B
Citric Acid
(g/L)		C
Sodium Citrate
(g/L)
10.30.50.5
20.40.60.6
30.50.70.7
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Liu, L.; Bai, M.; Zhang, S.; Li, J.; Liu, X.; Sen, B.; Wang, G. ARTP Mutagenesis of Schizochytrium sp. PKU#Mn4 and Clethodim-Based Mutant Screening for Enhanced Docosahexaenoic Acid Accumulation. Mar. Drugs 2021, 19, 564. https://doi.org/10.3390/md19100564

AMA Style

Liu L, Bai M, Zhang S, Li J, Liu X, Sen B, Wang G. ARTP Mutagenesis of Schizochytrium sp. PKU#Mn4 and Clethodim-Based Mutant Screening for Enhanced Docosahexaenoic Acid Accumulation. Marine Drugs. 2021; 19(10):564. https://doi.org/10.3390/md19100564

Chicago/Turabian Style

Liu, Lu, Mohan Bai, Sai Zhang, Jiantao Li, Xianhua Liu, Biswarup Sen, and Guangyi Wang. 2021. "ARTP Mutagenesis of Schizochytrium sp. PKU#Mn4 and Clethodim-Based Mutant Screening for Enhanced Docosahexaenoic Acid Accumulation" Marine Drugs 19, no. 10: 564. https://doi.org/10.3390/md19100564

APA Style

Liu, L., Bai, M., Zhang, S., Li, J., Liu, X., Sen, B., & Wang, G. (2021). ARTP Mutagenesis of Schizochytrium sp. PKU#Mn4 and Clethodim-Based Mutant Screening for Enhanced Docosahexaenoic Acid Accumulation. Marine Drugs, 19(10), 564. https://doi.org/10.3390/md19100564

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop